Prosecution Insights
Last updated: August 18, 2026

Examiner: CROW, ROBERT THOMAS

Tech Center 4100 • Art Units: 1634 1656 1677 1681 1682 1683 1699 1798 4100 4144

This examiner grants 42% of resolved cases

Performance Statistics

41.7%
Allow Rate
-18.3% vs TC avg
768
Total Applications
+32.1%
Interview Lift
1454
Avg Prosecution Days
Based on 715 resolved cases, 2023–2026

Rejection Statute Breakdown

2.3%
§101 Eligibility
9.2%
§102 Novelty
39.7%
§103 Obviousness
32.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18889917 METHOD FOR NANOPORE RNA CHARACTERISATION Non-Final OA Oxford Nanopore Technologies PLC
18010826 METHOD Non-Final OA Oxford Nanopore Technologies PLC
18160816 METHOD Non-Final OA Oxford Nanopore Technologies PLC
18065735 ENZYME STALLING METHOD Non-Final OA Oxford Nanopore Technologies PLC
17929809 METHODS AND SYSTEMS FOR PROCESSING TIME-RESOLVED SIGNAL INTENSITY DATA Final Rejection The Regents of The University of Michigan
17783750 COMPOSITIONS AND METHODS FOR LIGHT-DIRECTED BIOMOLECULAR BARCODING Final Rejection PRESIDENT AND FELLOWS OF HARVARD COLLEGE
18050688 METHODS AND COMPOSITIONS USEFUL FOR NUCLEIC ACID SEQUENCING Non-Final OA Singular Genomics Systems, Inc.
17979195 SINGLE-CELL RNA SEQUENCING USING CLICK-CHEMISTRY Non-Final OA Massachusetts Institute of Technology
18423678 HYBRIDIZATION COMPOSITIONS AND METHODS USING FORMAMIDE Non-Final OA Agilent Technologies, Inc.
18453947 HYBRIDIZATION COMPOSITIONS AND METHODS Non-Final OA Agilent Technologies, Inc.
19264527 SPATIALLY ENCODED BIOLOGICAL ASSAYS Final Rejection Prognosys Biosciences, Inc.
19264491 SPATIALLY ENCODED BIOLOGICAL ASSAYS Final Rejection Prognosys Biosciences, Inc.
18389877 MULTI-SURFACE BIOLOGICAL SAMPLE IMAGING SYSTEM AND METHOD Non-Final OA ILLUMINA, INC.
18467770 NANOPARTICLE WITH POLYNUCLEOTIDE BINDING SITE AND METHOD OF MAKING THEREOF Final Rejection ILLUMINA, INC
18343696 SEQUENCING NANOPARTICLES AND METHODS OF MAKING THE SAME Non-Final OA ILLUMINA, INC.
18176761 FUNCTIONALIZED NANOSTRUCTURES AND FLOW CELL DEPRESSIONS Final Rejection ILLUMINA, INC.
18164341 Microfluidic Droplet Generators Non-Final OA ILLUMINA, INC.
18106198 COMPOSITIONS FOR USE IN POLYUNUCLEOTIDE SEQUENCING Non-Final OA ILLUMINA CAMBRIDGE LIMITED
17338590 SYSTEMS AND METHODS FOR SEQUENCING NUCLEOTIDES USING TWO OPTICAL CHANNELS Non-Final OA Illumina Cambridge Limited
18348235 TRANSLOCATION CONTROL FOR SENSING BY A NANOPORE Non-Final OA Roche Sequencing Solutions, Inc.
18533836 METHOD FOR ISOLATING NUCLEIC ACIDS FROM A FORMALDEHYDE RELEASER STABILIZED SAMPLE Final Rejection QIAGEN GmbH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month